Efficacy, Retention, and Tolerability of Brivaracetam in Patients With Epileptic Encephalopathies: A Multicenter Cohort Study From Germany-Reference-Cited by-同舟云学术

Efficacy, Retention, and Tolerability of Brivaracetam in Patients With Epileptic Encephalopathies: A Multicenter Cohort Study From Germany

Published:2018-07-23 Issue: Volume:9 Page:
ISSN:1664-2295
Container-title:Frontiers in Neurology
language:
Short-container-title:Front. Neurol.

Author:

Willems Laurent M.,Bertsche Astrid,Bösebeck Frank,Hornemann Frauke,Immisch Ilka,Klein Karl M.,Knake Susanne,Kunz Rhina,Kurlemann Gerhard,Langenbruch Lisa,Möddel Gabriel,Müller-Schlüter Karen,von Podewils Felix,Reif Philipp S.,Steinhoff Bernhard J.,Steinig Isabel,Rosenow Felix,Schubert-Bast Susanne,Strzelczyk Adam

Publisher

Frontiers Media SA

Subject

Clinical Neurology,Neurology

Reference52 articles.

1. Brivaracetam in the treatment of focal and idiopathic generalized epilepsies and of status epilepticus;Strzelczyk;Expert Rev Clin Pharmacol.,2016

2. Treatment of refractory and super-refractory status epilepticus with brivaracetam: a cohort study from two German university hospitals;Strzelczyk;Epilepsy Behav.,2017

3. Efficacy and safety of brivaracetam for partial-onset seizures in 3 pooled clinical studies;Ben-Menachem;Neurology,2016

4. Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial;Biton;Epilepsia,2014

5. A randomized, double-blind, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial-onset seizures;Klein;Epilepsia,2015

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brivaracetam as add-on therapy in children with developmental epileptic encephalopathies: A study of 42 patients;Epilepsy & Behavior;2024-01

2. Efficacy and tolerability of add‐on stiripentol in real‐world clinical practice: An observational study in Dravet syndrome and non‐Dravet developmental and epileptic encephalopathies;Epilepsia Open;2023-11-08

3. Current and emerging pharmacotherapy for the treatment of Lennox-Gastaut syndrome;Expert Opinion on Pharmacotherapy;2023-06-05

4. BRIVEST: A ‘real-world’ observational, single-centre study investigating the efficacy, safety and tolerability of Brivaracetam;Epilepsy & Behavior;2023-01

5. Narrative review of brivaracetam for genetic generalized epilepsies;Seizure;2022-12